Discussion regarding how the presence of the complex allele [L467F;F508del] in the CFTR gene influences the effectiveness of CFTR modulator therapies (such as ivacaftor+lumacaftor, ivacaftor+tezacaftor, and ivacaftor+tezacaftor+elexacaftor) in treating cystic fibrosis patients.